The Status Quo of Diagnosis & Treatment of Pediatric Outpatients With

Status Recruiting

Clinical Trial Summary

A cross-sectional study is expected to conducted by inquiring about the history, diagnosis results and medication details of respiratory diseases of the outpatient pediatric patients with respiratory diseases in the pediatric departments at specialist children's hospital at the second class and above, general hospitals and maternal and child healthcare hospitals. About 10,000 electronic questionnaires are expected to be collected in total, with about 100 participating hospitals and 100 electronic questionnaires from each participating hospital.Diagnosis and treatment information of pediatric patients are expected to be collected in the third week in April, July and October 2021 and in January 2022.

Clinical Trial Description

Respiratory diseases are easy-to-transmit among and are common in children, especially acute respiratory infections in children which contribute to more than 60% of pediatric outpatient cases. In pediatric internal medicine outpatient cases, trachitis/bronchitis, acute upper respiratory tract infection, pneumonia, acute tonsillitis and asthma are the most common diseases torturing pediatric patients. Children are prone to recurrent respiratory infections which may impose heavy burdens on their families. Ten million children under 5 years old are killed by recurrent respiratory infections every year. In China, daily outpatient visits of children with recurrent upper respiratory tract infections account for 10%-20% of the total daily outpatient visits for respiratory diseases. The outpatient medication for pediatric patients is found of non-compliance issues. According to the data in 2014, more than 33.8% of pediatric patients of all ages were given off-label medication, and more than 30% were given off-label medication in treatment. The trial will be completed in 1 years with 10,000 participants taken from hospitals in partnership with clinical research collaboration of National Clinical Research Center for Respiratory Diseases, China, and analyze the status quo of diagnosis results and medication details of respiratory diseases of the outpatient pediatric patients with respiratory diseases in China. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04855604
Study type	Observational
Source	Beijing Children's Hospital
Contact	Baoping Xu, MD,PhD
Phone	861059616308
Email	xubaopingbch@163.com
Status	Recruiting
Phase
Start date	April 20, 2021
Completion date	January 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04461821` - Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and Adolescents
Recruiting	`NCT06267859` - Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children	Early Phase 1
Completed	`NCT04386408` - Evaluation of the Effect of a Combination of Plant Extracts (BSL_EP027) on the Incidence of Respiratory Infections	Phase 1
Recruiting	`NCT06229613` - Exhaled Breath Aerosol for the Etiological Diagnosis of Respiratory Tract Infections: a Pilot Study
Completed	`NCT02084043` - In Vitro Assessment of a Breath-synchronized Vibrating Mesh Nebulizer During Non Invasive Ventilation	N/A
Completed	`NCT01113255` - Validation of a Simulated Clinical Evaluation of Ventilators	Phase 2/Phase 3
Completed	`NCT00988000` - Initial Specialist Telephone Consultation With New Patients in Secondary Care	N/A
Completed	`NCT06454513` - Efficacy of Different Anesthesia Methods in Transbronchial Biopsy
Completed	`NCT02723890` - The Efficacy and Safety of Using the Novel Tyto Device	N/A
Completed	`NCT00719784` - Vibration Response Imaging in the Diagnosis of Pulmonary Disease	N/A
Completed	`NCT00823056` - The Effect of Probiotics on Infections in Toddlers	Phase 3
Recruiting	`NCT06366113` - Time of Exercise Re-training With Chronic Obstructive Pulmonary Disease (COPD)	N/A
Recruiting	`NCT05175313` - Transthoracic Ultrasonography Findings and Their Relation to Spirometric Indices in Patients With Obstructive and Restrictive Respiratory Diseases
Completed	`NCT02754947` - Need for the Assessment and Consultation Team (ACT) Following Anesthetic Care
Completed	`NCT01255592` - Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis	Phase 2
Completed	`NCT00840723` - Bronchoscopy Assisted Sampling of Cells and Fluid From the Lower Respiratory Tract of Human Subjects	N/A
Completed	`NCT05978011` - 2014TP001 - Assessing the Biology of the Injured Lung - Version 1
Recruiting	`NCT02717650` - The Alfred Step Test Exercise Protocol (A-STEP), for Adults With Cystic Fibrosis.	N/A
Completed	`NCT01196533` - A Comparative Clinical Trial of the TensorTip, a Novel Non Invasive Device for Measurement Blood Parameters	N/A
Completed	`NCT02406053` - Oxidative Damage and Antioxidant Mechanisms in COPD	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Status Quo of Diagnosis and Treatment of Pediatric Outpatients With Respiratory Diseases

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms